• Info
  • Insider Ownership

Insider Trading & Ownership of Steve Elms

Location
New York, NY
Summary
The estimated net worth of Steve Elms is at least $34,189,812 dollars as of 09 Mar 2026. Steve Elms is the Director of ADMA BIOLOGICS, INC. and owns shares of ADMA BIOLOGICS, INC. (ADMA) stock worth about $33.14M. Steve Elms is the Director of Marker Therapeutics, Inc. and owns shares of Marker Therapeutics, Inc. (MRKR) stock worth about $1.05M.
Signature
/s/ Steve Elms, by Michael A. Goldstein as Attorney-in-fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Steve Elms and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Quick Takeaways

  • Steve Elms has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $34,189,812.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: ADMA BIOLOGICS, INC. ($33,139,130).
  • Past-year value change for that position: -$8,611,913.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Steve Elms

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ADMA ADMA BIOLOGICS, INC. Director $33,139,130 -$8,611,913 -21% 05 Mar 2026
MRKR Marker Therapeutics, Inc. Director $1,050,682 17 Nov 2025
ELEV Elevation Oncology, Inc. Director 23 Jul 2025
ZSAN Zosano Pharma Corp Director 10 Jun 2021

Insider Transactions Reported by Steve Elms:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.